Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Benin

Benin

The revenue in the Other Vaccines market in Benin is forecasted to reach US$1.59m in 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 10.50%, leading to a market volume of US$2.62m by 2029.
In terms of global comparison, United States is projected to generate the highest revenue, amounting to US$24,730.00m in 2024.
Benin is experiencing a rise in demand for other vaccines due to increasing awareness of the importance of immunization.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

Benin, a West African country, has been experiencing a surge in demand for vaccines, including Other Vaccines.

Customer preferences: The population of Benin has been showing an increased awareness of the importance of vaccines, leading to a rise in demand for Other Vaccines. The government has been actively promoting vaccination campaigns, and this has led to an increase in the number of people seeking vaccination.

Trends in the market: The Other Vaccines market in Benin has been growing steadily over the years, with a significant increase in demand for vaccines. The rise in demand for Other Vaccines can be attributed to the increase in awareness of the importance of vaccination, coupled with the government's efforts to promote vaccination campaigns. The demand for Other Vaccines has been driven by the need to prevent diseases such as meningitis, yellow fever, and typhoid fever.

Local special circumstances: Benin has experienced outbreaks of vaccine-preventable diseases, such as meningitis and yellow fever, in the past. This has led to an increased awareness of the importance of vaccines in the country. The government has been working to improve access to vaccines, particularly in rural areas, and this has contributed to the growth of the Other Vaccines market.

Underlying macroeconomic factors: Benin's economy has been growing steadily in recent years, with a focus on improving healthcare infrastructure. The government has been investing in healthcare, and this has contributed to the growth of the Other Vaccines market. Additionally, the country has been receiving support from international organizations, such as the World Health Organization, to improve access to vaccines. This support has helped to drive the growth of the Other Vaccines market in Benin.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.